Encysive Pharmaceuticals, Inc. (NASDAQ:ENCY.DL)
CAPS Rating:
A global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked ENCY.DL yet. Tell us why you think ENCY.DL will outperform or underperform the market.
RSS Headlines
Fool UK
